BLUEWILLOW BIOLOGICS, INC. – Trademark Portfolio
Entity Type: 03
BLUEWILLOW BIOLOGICS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NANOVAX, BLUEWILLOW BIOLOGICS, and NANOBIO PROTECT NEXT LEVEL PROTECTION. The owner is based in ANN ARBOR, MI.
2311 GREEN ROAD
SUITE A
ANN ARBOR, MI 48105
Showing of trademarks Trademarks
Trademark Classifications
BLUEWILLOW BIOLOGICS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does BLUEWILLOW BIOLOGICS, INC. have?
BLUEWILLOW BIOLOGICS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does BLUEWILLOW BIOLOGICS, INC. file in?
BLUEWILLOW BIOLOGICS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BLUEWILLOW BIOLOGICS, INC.'s most well-known trademarks?
BLUEWILLOW BIOLOGICS, INC.'s registered trademark portfolio includes well-known marks such as NANOVAX, BLUEWILLOW BIOLOGICS, and NANOBIO PROTECT NEXT LEVEL PROTECTION. These are among 3 currently registered trademarks in the portfolio.
What is BLUEWILLOW BIOLOGICS, INC.'s trademark registration success rate?
BLUEWILLOW BIOLOGICS, INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.